乳腺癌骨转移风险分层的瘤内异质性影像生物标志物
本研究系统比较了两种瘤内异质性建模策略(特征级ITH1与栖息地ITH2)预测乳腺癌骨转移无病生存的效能,发现ITH1在预后性能和泛化性上均优于ITH2。联合ITH1评分、全瘤区影像组学及视觉Transformer特征的多维模型显著提升预测能力,最终整合模型的C指数达0.878~0.908。
要点
- 特征级异质性编码ITH1比栖息地建模ITH2更稳健,对骨转移预测贡献最突出。
- 多维度整合ITH1、全瘤区影像组学和ViT特征可显著提升骨转移风险分层效能。
- 最终模型集成临床影像变量后C指数达0.878~0.908,对个体化风险分层有潜在价值。
核心结论
- 特征级ITH编码比栖息地建模能更有效、更稳健地表征与乳腺癌骨转移相关的瘤内异质性。
- ITH、全瘤区影像组学与ViT特征的多维整合可实现对肿瘤互补表征并大幅增强个体化风险分层能力。
研究设计与样本
- 研究类型为预测模型构建与比较研究,系统比较ITH1、ITH2、全瘤区影像组学及ViT深度学习特征。
- 结局指标为骨转移无病生存(BMFS),并评估多维整合模型及SHAP可解释性分析。
关键影像表现/征象
- 特征级异质性编码基于肿瘤影像组学特征复杂度构建,不依赖空间分区,显示更强的稳健性与泛化性。
- 栖息地异质性基于超体素分割的区域聚合,区内特征趋于均质化,对骨转移相关异质性捕获能力较弱。
诊断标准与关键数值
- ITH1的预后表现与泛化性均优于ITH2。
- 最终整合模型纳入临床影像变量后一致性指数范围为0.878~0.908。
- ITH1评分与全瘤区影像组学及ViT评分联合显著提升BMFS预测效能。
- SHAP分析显示ITH1评分对骨转移风险预测贡献最大。
临床应用与阅片要点
- 在乳腺癌骨转移风险评估中,应优先采用基于特征复杂度编码的异质性指标而非栖息地分区指标。
- 报告系统可考虑整合异质性评分、全瘤区影像组学及深度学习特征进行联合解读。
- 临床影像变量与异质性评分的联合模型可辅助骨转移个体化风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Breast cancer carries a substantial long-term risk of bone metastasis, which marks progression to incurable disease and severely compromises patient quality of life. Conventional clinicopathological factors provide limited individualized prognostic resolution, highlighting the need for noninvasive biomarkers capable of capturing tumor biology relevant to bone-specific metastatic progression.
MATERIALS AND METHODS: We systematically compared two commonly used intratumoral heterogeneity (ITH) modeling strategies: feature-level heterogeneity encoding based on tumor radiomics features complexity (ITH1) and habitat-based regional aggregation derived from supervoxel partitioning (ITH2). Prognostic performance for bone metastasis-free survival (BMFS) was also evaluated by global tumor region (GTR) radiomics and vision transformer (ViT)-derived deep learning features. Multidimensional models integrating imaging-derived scores and clinicoradiological variables were constructed and interpreted using SHapley Additive exPlanations (SHAP).
RESULTS: ITH1 consistently outperformed ITH2 in prognostic performance and generalizability, indicating greater robustness in capturing tumor heterogeneity relevant to bone metastasis. Integration of the ITH1 score with GTR radiomics and ViT scores significantly improved BMFS prediction compared with any single modality. The final integrated model incorporating clinicoradiological variables achieved high and stable discrimination across cohorts, with concordance index values ranging from 0.878 to 0.908. SHAP analysis revealed that the ITH1 score contributed most prominently to bone metastasis risk prediction, underscoring the critical role of tumor heterogeneity in bone-specific metastatic risk.
CONCLUSION: Feature-level ITH encoding provides a more informative and robust representation of ITH than habitat-based modeling for predicting breast cancer bone metastasis. Multidimensional integration of ITH, GTR radiomics, and ViT-derived features enables complementary tumor characterization and substantially enhances individualized risk stratification, supporting its potential utility in precision oncology.
引用
- Sun, Zhang, Wang, et al. Intratumoral Heterogeneity-aware Imaging Biomarkers for Bone Metastasis Risk Stratification in Breast Cancer. Acad Radiol. 2026. PMID: 42648923. doi:10.1016/j.acra.2026.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。